<DOC>
	<DOCNO>NCT01010698</DOCNO>
	<brief_summary>The Biopharmaceutics Classification System ( BCS ) employ US FDA categorize drug substance 4 class characterize drug term aqueous solubility intestinal permeability . The four BCS category drug substance Class 1 , Class 2 , Class 3 , Class 4 . Biopharmaceutical property aqueous solubility intestinal permeability drug product dissolution determine rate extent drug absorption immediate-release ( IR ) solid oral dosage form ( e.g . tablet , capsule ) . Each class exhibit information regard biopharmaceutic property bioequivalence . For example , Class 1 drug favorable oral biopharmaceutic property ( high solubility high permeability ) . With biopharmaceutic property class 1 drug , result vivo bioequivalence ( BE ) study rapidly dissolve IR solid oral dosage form FDA provide waiver . This approach alone result new generic drug approve base vitro data alone ( i.e . biowaived ) , great saving resource reduction unnecessary human test . Objectives : 1 ) The primary objective study ass whether common excipients cause bioinequivalence Class 3 drug . 2 ) The secondary objective result study contribute towards provide scientific evidence FDA consideration Class 3 drug BCS-based biowaivers . Hypotheses : The investigator anticipate common excipients cause bioinequivalence . 1 ) Hence , hypothesize study commonly use excipients oral medication ( tablet , capsule ) modulate rate extent Class 3 drug absorption result bioinequivalence . 2 ) Alternative hypothesis commonly use excipients oral medication ( tablet , capsule ) modulate rate extent Class 3 drug absorption result bioinequivalence .</brief_summary>
	<brief_title>Class 3 Biowaivers</brief_title>
	<detailed_description />
	<mesh_term>Acyclovir</mesh_term>
	<mesh_term>Cimetidine</mesh_term>
	<criteria>Male Female Age 1855 Healthy volunteer : Subjects good health , determine screen evaluation great 30 day first drug study visit Willing avoid caffeine contain product 24 hour prior day study visit Willing stop OTC medication 24 hour prior study visit Able provide inform consent Presence significant medical disease ( include cardiovascular , pulmonary , hematologic , endocrine , immunologic , neurologic , gastrointestinal psychiatric ) Presence hepatic , renal disease Pregnant woman , breast feeding try become pregnant Excessive alcohol use ( i.e . current physical , behavioral , personal manifestation relate abuse dependency alcohol ) Routine use ( i.e . daily weekly ) prescription medication except birth control pill Routine use ( i.e . daily weekly ) use acid blocker , antacid , antidiarrhea , stimulant , appetite suppressant , anti nausea medication drug modulate GI function Currently take cimetidine ( acyclovir ) medication know interact cimetidine ( acyclovir ) Allergic cimetidine ( acyclovir ) Undergoing therapy solid tumor blood malignancy Any condition opinion PI medical physician would increase risk subject interfere integrity study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>cimetidine</keyword>
	<keyword>acyclovir</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>excipient</keyword>
	<keyword>formulation</keyword>
</DOC>